ADELAIDE, Australia, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Avance Clinical, a full-service biotech-focused global contract ...
(Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected ...
Non-dilutive secured term loan from BrightArc Capital to fund operating expenses. Vancouver, British Columbia--(Newsfile Corp ...
Anika Therapeutics, Inc. (Nasdaq: ANIK), the global leader in the design, development, manufacturing and commercialization of ...
PICASSO, an investigator-sponsored study conducted by AP-HP in collaboration with INRAe and Gustave Roussy, evaluated the ...
The study demonstrated statistically significant efficacy advantages for zemprocitinib over placebo across the primary and ...
While Moderna preps an entry to the oncology market next year with a personalized cancer vaccine, COVID sales are holding ...
The presentation will be held on November 13, 2026, at 11:30 CET via digital webcast. Kristina Torfgård, CEO, Nicholas Waters ...
First advancement in the second-line treatment setting for recurrent or metastatic head and neck cancer in a decade, bringing ...
Akeso has out-licensed the exclusive rights to develop and commercialize ivonescimab in the United States and Canada, South ...
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to attend the following upcoming investor ...
Now Accepting Applications: Founders’ Bench Award for Ophthalmology Innovation University Lab Partners (ULP), in partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results